Natural polymorphisms in Mycobacterium tuberculosis conferring resistance to delamanid in drug-naive patients
More about Open Access at the CrickAuthors list
Martina L Reichmuth Rico Hömke Kathrin Zürcher Peter Sander Anchalee Avihingsanon Jimena Collantes Chloé Loiseau Sonia Borrell Miriam Reinhard Robert Wilkinson Marcel Yotebieng Lukas Fenner Erik C Böttger Sebastien Gagneux Matthias Egger Peter M Keller International epidemiology Databases to Evaluate AIDS (IeDEA)Abstract
Mutations in the genes of the F420 signaling pathway, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, of Mycobacterium tuberculosis (Mtb) complex can lead to delamanid resistance. We searched for such mutations among 129 Mtb strains from Asia, South-America, and Africa using whole-genome sequencing; 70 (54%) strains had at least one mutation in one of the genes. For ten strains with mutations, we determined the minimum inhibitory concentration (MIC) of delamanid. We found one strain from a delamanid-naïve patient carrying the natural polymorphism Tyr29del (ddn) that was associated with a critical MIC to delamanid.
Journal details
Volume 64
Issue number 11
Pages e00513-20
Available online
Publication date
Full text links
Publisher website (DOI) 10.1128/AAC.00513-20
Figshare View on figshare
Europe PubMed Central 32868333
Pubmed 32868333
Keywords
Related topics
Type of publication